The mission of the Data Science Shared Resource (DSSR) is to provide professional expertise in biostatistics, bioinformatics and clinical research informatics for all Vanderbilt-Ingram Cancer Center (VICC) investigators. Functions provided by the DSSR include: development of experimental designs, power and sample size analysis; data acquisition and database development; patient identification within the electronic health record (eHR); statistical and bioinformatics analysis and interpretation of findings; collaboration on presentation of results; education in biostatistics and bioinformatics methods; and development of tools/methods with application to laboratory and clinical research. To achieve these functions, the DSSR Director, co-Director, and program leaders are constantly available to VICC investigators. The primary objectives of the DSSR are: 1) to ensure scientific rigor and reproducibility in all VICC studies through key services: experimental design; accurate and reliable data capture; and appropriate, reproducible analysis techniques; 2) to provide study design and power and sample size analysis, as well as to review all laboratory, animal, clinical, omics and prevention studies, including a feasibility assessment that considers both technical feasibility as well as patient population analytics (as appropriate); 3) to collaborate in providing statistical and bioinformatics data analysis, interpretation of results, and the writing of final study reports and manuscripts; 4) to develop and evaluate statistical and bioinformatics methods and software for experimental design, visualization and data analysis; 5) to provide custom database design, data entry, data tracking, forms, queries, and reports, and to maintain electronic data capture (EDC) systems for information storage and retrieval, as well as for study, participant, and/or specimen management, for investigator-initiated clinical trials, other clinical research, or laboratory studies; 6) to work with the Clinical Trials Shared Resource (CTSR) and VICC investigators to develop research project databases, to maintain data quality control and ensure timely data capture; 7) to work with the Genomic Sciences Shared Resource (GSSR) in the development of bioinformatics tools and pipelines, to ensure data quality control and provide novel computational biology support; 8) to train VICC members in research design and data analysis through seminars, workshops and individual sessions; 9) to catalyze research productivity by providing common informatics support including software development, shared research applications and shared research infrastructure; 10) to aid in translating ?genomically-enabled? best practices into clinical decision support; 11) to develop infrastructure, processes and frameworks to aid in identifying patient populations within the electronic health record; 12) to ensure HIPAA compliance in use of patient data by maintaining privacy standards and creating limited or de-identified datasets as appropriate to IRB-approved study aims.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024637
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Werfel, Thomas A; Wang, Shan; Jackson, Meredith A et al. (2018) Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Res 78:1845-1858

Showing the most recent 10 out of 2462 publications